Is BNOEF or SBUX a better dividend investment in 2026?

BNOEF currently yields 33333.33% with a 5% 5-year dividend growth rate. SBUX yields 2.84% with 5% growth. The better choice depends on your goal: BNOEF offers higher current income.

What is the dividend yield difference between BNOEF and SBUX?

BNOEF has a forward dividend yield of 33333.33% ($2.00/share annually). SBUX yields 2.84% ($2.46/share annually). The yield gap is 33330.49 percentage points.

Home › Compare › BNOEF vs SBUX

BNOEF vs SBUX: Dividend Comparison 2026

BNOEF yields 33333.33% · SBUX yields 2.84%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 BNOEF wins by $8.428195308647591e+21M in total portfolio value

INVESTMENT

TIME HORIZON10 years

BNOEF

● Live price

33333.33%

Share price

$0.01

Annual div

$2.00

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$8.428195308647591e+21M

Annual income

$8,378,748,509,141,157,000,000,000,000.00

Full BNOEF calculator →

SBUX

● Live price

2.84%

Share price

$86.72

Annual div

$2.46

5Y div CAGR

48.3%

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$167.0K

Annual income

$71,136.45

Full SBUX calculator →

Portfolio growth — BNOEF vs SBUX

📍 BNOEF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	BNOEF	SBUX
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, BNOEF + SBUX cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

BNOEF pays

SBUX pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

BNOEF

Annual income on $10K today (after 15% tax)

$2,833,333.33/yr

After 10yr DRIP, annual income (after tax)

$7,121,936,232,769,983,000,000,000,000.00/yr

SBUX

Annual income on $10K today (after 15% tax)

$241.12/yr

After 10yr DRIP, annual income (after tax)

$60,465.98/yr

At 15% tax rate, BNOEF beats the other by $7,121,936,232,769,983,000,000,000,000.00/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of BNOEF + SBUX for your $10,000?

BNOEF: 50%SBUX: 50%

100% SBUX50/50100% BNOEF

Portfolio after 10yr

$4.2140976543237957e+21M

Annual income

$4,189,374,254,570,578,700,000,000,000.00/yr

Blended yield

99.41%

📊

Analyst Conviction Gap

Where Wall Street is most bullish on SBUX right now

BNOEF

No analyst data

Altman Z

-5.0

Piotroski

6/9

SBUX

Analyst Ratings

Buy

Hold

Sell

Consensus: Buy

Price Target

$104.00

+19.9% upside vs current

Range: $90.00 — $120.00

Altman Z

2.6

Piotroski

5/9

Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

BNOEF buys

SBUX buys

No recent congressional trades found for BNOEF or SBUX in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricBNOEFSBUX

Forward yield	33333.33% ✓	2.84%
Annual dividend / share	$2.00	$2.46 ✓
Payout ratio	50%	50%
1-year div growth	0%	0%
5-year div CAGR	0%	48.3% ✓
Portfolio after 10y	$8.428195308647591e+21M	$167.0K ✓
Annual income after 10y	$8,378,748,509,141,157,000,000,000,000.00 ✓	$71,136.45
Total dividends collected	$8.424943808765552e+21M	$136.4K ✓
Payment frequency	quarterly	quarterly
Sector	Stock	Consumer Discretionary

Year-by-year: BNOEF vs SBUX ($10,000, DRIP)

Year	BNOEF Portfolio	BNOEF Income/yr	SBUX Portfolio	SBUX Income/yr	Gap
1← crossover	$3,344,033	$3,333,333.33	$11,121	$420.68	+$3.33M → BNOEF
2	$1,045,333,048	$1,041,754,932.50	$12,548	$648.40	+$1045.32M → BNOEF
3	$305,463,295,767	$304,344,789,404.97	$14,440	$1,013.98	+$305463.28M → BNOEF
4	$83,443,192,327,233	$83,116,346,600,762.75	$17,068	$1,617.30	+$83443192.31M → BNOEF
5	$21,308,754,850,592,396	$21,219,470,634,802,260.00	$20,912	$2,649.52	+$21308754850.57M → BNOEF
6	$5,087,082,937,849,453,000	$5,064,282,570,159,319,000.00	$26,875	$4,499.29	+$5087082937849.43M → BNOEF
7	$1,135,355,897,925,379,400,000	$1,129,912,719,181,880,500,000.00	$36,771	$8,014.12	+$1135355897925379.50M → BNOEF
8	$236,895,694,937,506,160,000,000	$235,680,864,126,726,020,000,000.00	$54,542	$15,197.11	+$236895694937506176.00M → BNOEF
9	$46,211,962,155,546,610,000,000,000	$45,958,483,761,963,480,000,000,000.00	$89,602	$31,242.49	+$46211962155546607616.00M → BNOEF
10	$8,428,195,308,647,591,000,000,000,000	$8,378,748,509,141,157,000,000,000,000.00	$167,011	$71,136.45	+$8.428195308647591e+21M → BNOEF

BNOEF vs SBUX: Complete Analysis 2026

BNOEF — Stock

Bionomics Limited, a clinical stage biopharmaceutical company, discovers and develops novel drug candidates for the treatment of central nervous system disorders and cancers. The company's lead drug candidate includes BNC210, a negative allosteric modulator of the a7 nicotinic acetylcholine receptor, which is in phase 2 clinical trial for the treatment of social anxiety disorder and phase 2b to treat post-traumatic stress disorder. It also develops BNC101, a monoclonal antibody that has completed phase 1 clinical trial that targets cancer stem cells; and BNC105, which is in phase 2 clinical trial for the treatment of refractory colorectal cancer and phase 1 clinical trial for the treatment of patients with relapsed/refractory chronic lymphocytic leukemia. Bionomics Limited was incorporated in 1996 and is based in Eastwood, Australia.

Full BNOEF Calculator →

SBUX — Consumer Discretionary

Starbucks Corporation, together with its subsidiaries, operates as a roaster, marketer, and retailer of specialty coffee worldwide. The company operates through three segments: North America, International, and Channel Development. Its stores offer coffee and tea beverages, roasted whole beans and ground coffees, single serve products, and ready-to-drink beverages; and various food products, such as pastries, breakfast sandwiches, and lunch items. The company also licenses its trademarks through licensed stores, and grocery and foodservice accounts. The company offers its products under the Starbucks, Teavana, Seattle's Best Coffee, Evolution Fresh, Ethos, Starbucks Reserve, and Princi brands. As of October 3, 2021, it operated 16,826 company-operated and licensed stores in North America; and 17,007 company-operated and licensed stores internationally. The company was founded in 1971 and is based in Seattle, Washington.

Full SBUX Calculator →

📬

Get this BNOEF vs SBUX comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

BNOEF vs SCHD BNOEF vs JEPI BNOEF vs O BNOEF vs KO BNOEF vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.